List of Tables
Table 1. Global α-Glucosidase Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global α-Glucosidase Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global α-Glucosidase Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global α-Glucosidase Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global α-Glucosidase Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global α-Glucosidase Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global α-Glucosidase Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market α-Glucosidase Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of α-Glucosidase Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of α-Glucosidase Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of α-Glucosidase Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of α-Glucosidase Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global α-Glucosidase Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on α-Glucosidase Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global α-Glucosidase Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global α-Glucosidase Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global α-Glucosidase Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global α-Glucosidase Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global α-Glucosidase Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global α-Glucosidase Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global α-Glucosidase Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global α-Glucosidase Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global α-Glucosidase Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America α-Glucosidase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America α-Glucosidase Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America α-Glucosidase Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe α-Glucosidase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe α-Glucosidase Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe α-Glucosidase Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific α-Glucosidase Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific α-Glucosidase Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific α-Glucosidase Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific α-Glucosidase Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific α-Glucosidase Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America α-Glucosidase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America α-Glucosidase Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America α-Glucosidase Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa α-Glucosidase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa α-Glucosidase Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa α-Glucosidase Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa α-Glucosidase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global α-Glucosidase Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global α-Glucosidase Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global α-Glucosidase Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global α-Glucosidase Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global α-Glucosidase Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global α-Glucosidase Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global α-Glucosidase Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global α-Glucosidase Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global α-Glucosidase Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global α-Glucosidase Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global α-Glucosidase Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global α-Glucosidase Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global α-Glucosidase Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global α-Glucosidase Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global α-Glucosidase Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global α-Glucosidase Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global α-Glucosidase Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global α-Glucosidase Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global α-Glucosidase Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global α-Glucosidase Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer α-Glucosidase Inhibitors Product
Table 74. Bayer Recent Developments/Updates
Table 75. Bluepharma Company Information
Table 76. Bluepharma Description and Business Overview
Table 77. Bluepharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bluepharma α-Glucosidase Inhibitors Product
Table 79. Bluepharma Recent Developments/Updates
Table 80. Strides Pharma Company Information
Table 81. Strides Pharma Description and Business Overview
Table 82. Strides Pharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Strides Pharma α-Glucosidase Inhibitors Product
Table 84. Strides Pharma Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sun Pharmaceutical α-Glucosidase Inhibitors Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Takeda Company Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Takeda α-Glucosidase Inhibitors Product
Table 94. Takeda Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Pfizer α-Glucosidase Inhibitors Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Lunan Pharma Company Information
Table 101. Lunan Pharma Description and Business Overview
Table 102. Lunan Pharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Lunan Pharma α-Glucosidase Inhibitors Product
Table 104. Lunan Pharma Recent Developments/Updates
Table 105. SUN Pharma Company Information
Table 106. SUN Pharma Description and Business Overview
Table 107. SUN Pharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. SUN Pharma α-Glucosidase Inhibitors Product
Table 109. SUN Pharma Recent Developments/Updates
Table 110. Lupin Pharma Company Information
Table 111. Lupin Pharma Description and Business Overview
Table 112. Lupin Pharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Lupin Pharma α-Glucosidase Inhibitors Product
Table 114. Lupin Pharma Recent Developments/Updates
Table 115. Glenmark Pharma Company Information
Table 116. Glenmark Pharma Description and Business Overview
Table 117. Glenmark Pharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Glenmark Pharma α-Glucosidase Inhibitors Product
Table 119. Glenmark Pharma Recent Developments/Updates
Table 120. Shandong New Time Pharmaceutical Company Information
Table 121. Shandong New Time Pharmaceutical Description and Business Overview
Table 122. Shandong New Time Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Shandong New Time Pharmaceutical α-Glucosidase Inhibitors Product
Table 124. Shandong New Time Pharmaceutical Recent Developments/Updates
Table 125. Weiao Pharmaceutical (Sichuan) Company Information
Table 126. Weiao Pharmaceutical (Sichuan) Description and Business Overview
Table 127. Weiao Pharmaceutical (Sichuan) α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Weiao Pharmaceutical (Sichuan) α-Glucosidase Inhibitors Product
Table 129. Weiao Pharmaceutical (Sichuan) Recent Developments/Updates
Table 130. Zhejiang Medicine Company Information
Table 131. Zhejiang Medicine Description and Business Overview
Table 132. Zhejiang Medicine α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Zhejiang Medicine α-Glucosidase Inhibitors Product
Table 134. Zhejiang Medicine Recent Developments/Updates
Table 135. Cisen Pharmaceutical Company Information
Table 136. Cisen Pharmaceutical Description and Business Overview
Table 137. Cisen Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Cisen Pharmaceutical α-Glucosidase Inhibitors Product
Table 139. Cisen Pharmaceutical Recent Developments/Updates
Table 140. Zhejiang Jingxin Pharmaceutical Company Information
Table 141. Zhejiang Jingxin Pharmaceutical Description and Business Overview
Table 142. Zhejiang Jingxin Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Zhejiang Jingxin Pharmaceutical α-Glucosidase Inhibitors Product
Table 144. Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
Table 145. Nanjing Hicin Pharmaceutical Company Information
Table 146. Nanjing Hicin Pharmaceutical Description and Business Overview
Table 147. Nanjing Hicin Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Nanjing Hicin Pharmaceutical α-Glucosidase Inhibitors Product
Table 149. Nanjing Hicin Pharmaceutical Recent Developments/Updates
Table 150. Beijing SL Pharmaceutical Company Information
Table 151. Beijing SL Pharmaceutical Description and Business Overview
Table 152. Beijing SL Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Beijing SL Pharmaceutical α-Glucosidase Inhibitors Product
Table 154. Beijing SL Pharmaceutical Recent Developments/Updates
Table 155. Jinri Pharmaceutical (China) Company Information
Table 156. Jinri Pharmaceutical (China) Description and Business Overview
Table 157. Jinri Pharmaceutical (China) α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Jinri Pharmaceutical (China) α-Glucosidase Inhibitors Product
Table 159. Jinri Pharmaceutical (China) Recent Developments/Updates
Table 160. Hangzhou East China Pharmaceutical Company Information
Table 161. Hangzhou East China Pharmaceutical Description and Business Overview
Table 162. Hangzhou East China Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Hangzhou East China Pharmaceutical α-Glucosidase Inhibitors Product
Table 164. Hangzhou East China Pharmaceutical Recent Developments/Updates
Table 165. Zhejiang Hisun Pharmaceutical Company Information
Table 166. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 167. Zhejiang Hisun Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Zhejiang Hisun Pharmaceutical α-Glucosidase Inhibitors Product
Table 169. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 170. CSPC Ouyi Pharmaceutical Company Information
Table 171. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 172. CSPC Ouyi Pharmaceutical α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. CSPC Ouyi Pharmaceutical α-Glucosidase Inhibitors Product
Table 174. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 175. Luye Pharma Company Information
Table 176. Luye Pharma Description and Business Overview
Table 177. Luye Pharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Luye Pharma α-Glucosidase Inhibitors Product
Table 179. Luye Pharma Recent Developments/Updates
Table 180. Livzon Pharm Company Information
Table 181. Livzon Pharm Description and Business Overview
Table 182. Livzon Pharm α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Livzon Pharm α-Glucosidase Inhibitors Product
Table 184. Livzon Pharm Recent Developments/Updates
Table 185. YaoPharma Company Information
Table 186. YaoPharma Description and Business Overview
Table 187. YaoPharma α-Glucosidase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. YaoPharma α-Glucosidase Inhibitors Product
Table 189. YaoPharma Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. α-Glucosidase Inhibitors Distributors List
Table 193. α-Glucosidase Inhibitors Customers List
Table 194. α-Glucosidase Inhibitors Market Trends
Table 195. α-Glucosidase Inhibitors Market Drivers
Table 196. α-Glucosidase Inhibitors Market Challenges
Table 197. α-Glucosidase Inhibitors Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of α-Glucosidase Inhibitors
Figure 2. Global α-Glucosidase Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global α-Glucosidase Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Acarbose Product Picture
Figure 5. Voglibose Product Picture
Figure 6. Miglitol Product Picture
Figure 7. Other Product Picture
Figure 8. Global α-Glucosidase Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 9. Global α-Glucosidase Inhibitors Market Share by Application: 2025 & 2032
Figure 10. Hospital and Clinic
Figure 11. Pharmacy
Figure 12. Other
Figure 13. Global α-Glucosidase Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global α-Glucosidase Inhibitors Market Size (US$ Million), 2021–2032
Figure 15. Global α-Glucosidase Inhibitors Sales (K Units), 2021–2032
Figure 16. Global α-Glucosidase Inhibitors Average Price (US$/Unit), 2021–2032
Figure 17. α-Glucosidase Inhibitors Report Years Considered
Figure 18. α-Glucosidase Inhibitors Sales Share by Manufacturers in 2025
Figure 19. Global α-Glucosidase Inhibitors Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global α-Glucosidase Inhibitors Players: Market Share by Revenue in α-Glucosidase Inhibitors in 2025
Figure 21. α-Glucosidase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global α-Glucosidase Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America α-Glucosidase Inhibitors Sales Market Share by Country (2021–2032)
Figure 24. North America α-Glucosidase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 25. United States α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe α-Glucosidase Inhibitors Sales Market Share by Country (2021–2032)
Figure 28. Europe α-Glucosidase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 29. Germany α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific α-Glucosidase Inhibitors Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific α-Glucosidase Inhibitors Revenue Market Share by Region (2021–2032)
Figure 36. China α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America α-Glucosidase Inhibitors Sales Market Share by Country (2021–2032)
Figure 44. Latin America α-Glucosidase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 45. Mexico α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa α-Glucosidase Inhibitors Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa α-Glucosidase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 51. Turkey α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE α-Glucosidase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of α-Glucosidase Inhibitors by Type (2021–2032)
Figure 55. Global Revenue Market Share of α-Glucosidase Inhibitors by Type (2021–2032)
Figure 56. Global α-Glucosidase Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of α-Glucosidase Inhibitors by Application (2021–2032)
Figure 58. Global Revenue Market Share of α-Glucosidase Inhibitors by Application (2021–2032)
Figure 59. Global α-Glucosidase Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 60. α-Glucosidase Inhibitors Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
